Asia-Pacific Infusion Pumps Market - 2024 - 2031

Report Overview

Asia-Pacific Infusion Pumps Market reached US$ 3.36 billion in 2023 and is expected to reach US$ 7.44 billion by 2031, growing at a CAGR of 10.7 % during the forecast period 2024-2031.

Infusion pumps are utilized extensively in the home and clinical environments such as nursing homes and hospitals. In contrast to manual administration, they provide numerous benefits, including the ability to administer fluids in minute quantities and at precisely programmed or automated intervals. They are utilized to administer medications or nutrients, including antibiotics, insulin or other hormones, painkillers, and chemotherapy medicines.

Infusion pumps allow for highly viscous medications to be administered through small catheters into the veins. Medication is usually administered this way through the dorsal veins of the hand, the forearm, the arm, the dorsal veins of the foot, the inguinal region, and the antecubital fossa.

Market Dynamics: Drivers & Restraints

Increasing geriatric population

The rising geriatric population is expected to be the significant driving factor for the market growth. Several diseases are increasing among elderly individuals. Older age is also characterized by the emergence of several complex health states commonly called geriatric syndromes.

Diabetes is one of the major diseases that attacks elderly individuals. To maintain the glucose levels in the patients, infusion pumps are used for insulin infusion and are adopted in homecare settings. IV fluids are used in the treatment of dehydration, a common cause of hospitalization and death in elderly adults particularly among those in nursing homes and at homes using infusion pumps.

Cancer is also considered the major diseases that attack older individuals and increase the demand for infusion pumps. Infusion pumps give a controlled amount of drugs very slowly into the bloodstream. There is an increasing demand for infusion pumps among older individuals. The incidence of cancer rises dramatically at a later stage in life. For instance, according to NITI Aayog survey in 2024, 75% of the elderly have one or more chronic diseases. Cancer prevalence is on the rise and is higher in urban India.

Regulatory hurdles

Regulatory limitations involved with approving infusion pumps are projected to hinder industry growth. Ensuring that infusion pumps meet tight regulatory requirements pays significant costs. These can include costs for clinical investigations, paperwork, quality control procedures, and GMP compliance. Startups and smaller companies could find these expenses too costly.

Market Segment Analysis

The Asia-Pacific infusion pumps market is segmented based on product type, application, and end-user.

The insulin infusion pumps segment is expected to dominate the market share

Insulin infusion pumps hold a significant portion of the market share and are expected to continue throughout the forecast period. This is due to the increasing adoption of infusion pumps in the treatment of diabetic patients. The growing number of diabetic patients is also expected to be one of the major factors for the increasing demand for infusion pumps.

For instance, according to the World Health Organization, in 2023, it is stated that in the WHO South-East Asia Region, more than 96 million people are estimated to have diabetes. Diabetes and its complications bring about substantial economic loss to people with diabetes and their families and to health systems and national economies.

Insulin pumps can help people with diabetes conveniently manage their blood sugar. These small, wearable devices deliver doses of insulin at specific times and are an alternative to multiple daily injections. The rising diabetic population is increasing the demand for insulin infusion pumps to deliver the correct dosages of insulin to patients. Thus, the above factors are expected to drive the segment growth and are expected to hold the segment in the dominant position.

Market Segmentation

By Product Type

Implantable Infusion Pumps

Insulin Infusion Pumps

Syringe Infusion Pumps

Volumetric Infusion Pumps

Others

By Application

Diabetes

Chemotherapy/Oncology

Gastroenterology

Analgesia/Pain Management

Pediatrics/Neonatology

Hematology

Others

By End-User

Hospitals & Clinics

Ambulatory Care Settings

Home Care Settings

Academic & Research Institutes

Others

Market Competitive Landscape

The major players in the market include Hawk Medical LLC, Shanghai Kindly Enterprise Development Group Co., Ltd., Takasago Electric, Inc., Inscon Medical Solutions Pvt. Ltd., Merck India, AKAS Medical Equipment, Ascensia Diabetes Care Holdings AG, RHC Medical, ARI Medical Technology Co., Ltd. and Shanghai Mekon Medical Devices Co., Ltd. among others.

Why Purchase the Report?

To visualize the Asia-Pacific infusion pumps market segmentation based on product type, application, and end-user, as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of infusion pumps market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as Excel consisting of key products of all the major players.

The Asia-Pacific infusion pumps market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies